Hot Stocks: Brokerage view on Zomato, M&M, Vedanta and Infosys

Brokerage firms such as JPMorgan maintained an overweight rating on Zomato, while Nomura maintained a buy rating on M&M, CLSA has a buy rating on Vedanta and Jefferies recommended a buy on Infosys.
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:JPMorgan on Zomato: Overweight | Target: Rs 208
Global brokerage JPMorgan maintained an overweight rating on Zomato with a target price of Rs 208. Zomato has been successful in some acquisitions, such as Uber Eats India, Runnr, and Blinkit.

Movies and Live Events can eventual adjacency to Dining Out. Paytm had a meaningful market share in the Movies and Events business as a clear #2.

Its decision to exit the business appears to be in line with its recent intention to prune “non-core businesses” in Q4.Nomura on M&M: Buy | Target: Rs 3,374
Nomura maintained a buy rating on M&M and raised the target price to Rs 3,374 from Rs 2,818 earlier.
Battery Electric Vehicle (BEVs) to drive into premium lane. The farm machinery segment also has high potential.
Exports and ‘growth gems’ have further upside. The global investment bank expects M&M to continue delivering market-beating growth across segments.CLSA on Vedanta: Buy | Target: Rs 520
CLSA maintained a buy rating on Vedanta but raised the target price to Rs 520 from Rs 430 earlier.

The focus is on operational improvements. Aluminium will be a key value driver through capacity additions, cost control, and a change in mix.

Improved earnings from Zinc and Crude oil are likely to be gradual and will be closely watched.

The global investment bank sees several operational catalysts for sustained outperformance of the stock.

Jefferies on Infosys: Buy | Target: Rs 1,630
Jefferies maintained a buy rating on Infosys with a target price of Rs 1,630. The management expects discretionary IT spending to remain under pressure given macro/tech uncertainties.

Growth in FY25 should be front-ended, thereby reducing the disconnect between growth and deal wins.

It sees multiple opportunities in Gen-Al and is investing heavily to augment its capabilities.

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of The Economic Times)